Fate Therapeutics Insiders US$207k Short Of Breakeven On Stock Purchase

Insiders who bought US$698.1k worth of Fate Therapeutics, Inc. ( NASDAQ:FATE ) stock in the last year have seen some of...

Related Keywords

,Fate Therapeutics ,Insider Transactions ,John Mendlein ,Nsider Ownership ,